Literature DB >> 25965444

Noninvasive diagnosis of liver fibrosis: The importance of being reimbursed.

Giada Sebastiani, Peter Ghali, Marc Deschenes, Philip Wong.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25965444      PMCID： PMC4444033          DOI： 10.1155/2015/943410

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN： 2291-2789


× No keyword cloud information.
  9 in total

1.  Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines?

Authors:  Laurent Castera; Jacques Denis; Gerard Babany; Françoise Roudot-Thoraval
Journal:  J Hepatol       Date:  2006-12-18       Impact factor: 25.083

2.  Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey.

Authors:  Giada Sebastiani; Peter Ghali; Phil Wong; Marina B Klein; Marc Deschenes; Robert P Myers
Journal:  Can J Gastroenterol Hepatol       Date:  2014-01

3.  An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver.

Authors:  Robert P Myers; Hemant Shah; Kelly W Burak; Curtis Cooper; Jordan J Feld
Journal:  Can J Gastroenterol Hepatol       Date:  2015-01-13

4.  Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.

Authors:  Julien Vergniol; Juliette Foucher; Eric Terrebonne; Pierre-Henri Bernard; Brigitte le Bail; Wassil Merrouche; Patrice Couzigou; Victor de Ledinghen
Journal:  Gastroenterology       Date:  2011-03-02       Impact factor: 22.682

5.  Patient preference and willingness to pay for transient elastography versus liver biopsy: A perspective from British Columbia.

Authors:  Victoria Yui-Min Kan; Vladimir Marquez Azalgara; Jo-Ann E Ford; W C Peter Kwan; Siegfried Roland Erb; Eric M Yoshida
Journal:  Can J Gastroenterol Hepatol       Date:  2015-03

6.  Occult cirrhosis diagnosed by transient elastography is a frequent and under-monitored clinical entity.

Authors:  Tianyan Chen; Remy Wong; Philip Wong; Kathleen C Rollet-Kurhajec; Rasha Alshaalan; Marc Deschenes; Peter Ghali; Giada Sebastiani
Journal:  Liver Int       Date:  2015-03-04       Impact factor: 5.828

7.  Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.

Authors:  Paul Angulo; Elisabetta Bugianesi; Einar S Bjornsson; Phunchai Charatcharoenwitthaya; Peter R Mills; Francisco Barrera; Svanhildur Haflidadottir; Christopher P Day; Jacob George
Journal:  Gastroenterology       Date:  2013-07-13       Impact factor: 22.682

8.  Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies.

Authors:  Robert P Myers; Andrew Fong; Abdel Aziz M Shaheen
Journal:  Liver Int       Date:  2008-05       Impact factor: 5.828

9.  Exceeding the limits of liver histology markers.

Authors:  Shruti H Mehta; Bryan Lau; Nezam H Afdhal; David L Thomas
Journal:  J Hepatol       Date:  2008-10-18       Impact factor: 25.083
  9 in total
  1 in total

1.  A Canadian survey on knowledge of non-alcoholic fatty liver disease among physicians.

Authors:  Giada Sebastiani; Alnoor Ramji; Mark G Swain; Keyur Patel
Journal:  Can Liver J       Date:  2021-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.